Athersys Inc - ESG Rating & Company Profile powered by AI
This SDG score for Athersys Inc represents the company's reporting of the United Nations SDGs. The dashboard includes a Q&A section for Athersys Inc. This analysis of Athersys Inc leverages data points from across the web as well as from public filings by Athersys Inc.
Athersys Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.3; made up of an environmental score of 8.0, social score of 1.6 and governance score of 3.2.
4.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 910 | Vaxcyte Inc | 4.4 | High |
| 910 | Yield10 Bioscience Inc | 4.4 | High |
| 951 | Athersys Inc | 4.3 | High |
| 951 | Cerecor Inc | 4.3 | High |
| 951 | Allergy Therapeutics PLC | 4.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Athersys Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Athersys Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Athersys Inc report the average age of the workforce?
Sign up for free to unlockDoes Athersys Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Athersys Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Athersys Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Athersys Inc offer flexible work?
Sign up for free to unlockDoes Athersys Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Athersys Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Athersys Inc conduct supply chain audits?
Sign up for free to unlockDoes Athersys Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Athersys Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Athersys Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Athersys Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Athersys Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Athersys Inc disclose water use targets?
Sign up for free to unlockDoes Athersys Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Athersys Inc have a product recall in the last two years?
Sign up for free to unlockDoes Athersys Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Athersys Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Athersys Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Athersys Inc disclose parental leave metrics?
Sign up for free to unlockDoes Athersys Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Athersys Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Athersys Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Athersys Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Athersys Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Athersys Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Athersys Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Athersys Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Athersys Inc disclose its waste policy?
Sign up for free to unlockDoes Athersys Inc report according to TCFD requirements?
Sign up for free to unlockDoes Athersys Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Athersys Inc disclose energy use targets?
Sign up for free to unlockDoes Athersys Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Athersys Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Athersys Inc
These potential risks are based on the size, segment and geographies of the company.
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.